Home » Posts tagged with » Seattle
Roche acquires DNA sequencing technology company Stratos Genomics

Roche acquires DNA sequencing technology company Stratos Genomics

Roche acquisition of Stratos Genomics : Swiss pharma giant Roche has acquired US-based early-stage DNA sequencing technology company Stratos Genomics for an undisclosed price. The transaction is expected to help Roche advance the development of its nanopore sequencer through the access to Sequencing by Expansion (SBX), Stratos Genomics’ unique chemistry. Roche said that once developed, […]

Frazier Healthcare Partners raises $617m for life sciences fund

Frazier Healthcare Partners has closed its third life sciences fund – Frazier Life Sciences X, at more than $617 million in capital commitments. The Seattle-based private equity and venture capital firm has been investing in life sciences since more than 29 years ago Since its inception, Frazier Healthcare Partners has raised its total committed capital to approximately $4.8 […]

Continue reading …
Icosavax, a new vaccine development company, launched in Seattle

Icosavax, a new pharma company, focused on developing vaccines against infectious diseases, has been launched in Seattle, Washington. The vaccine development company is backed by $51 million capital raised through a Series A financing round led by Qiming Venture Partners USA. Other investors in Icosavax are Sanofi Ventures, Adams Street Partners, and NanoDimension, alongside continuing […]

Continue reading …
Sound Pharmaceuticals bags FDA fast track status for SPI-1005 in Meniere’s Disease

US biopharma company Sound Pharmaceuticals said that its investigational drug SPI-1005 has secured the fast track designation (FTD) from the US Food and Drug Administration (FDA) for the treatment of Meniere’s Disease (MD), a disorder of the inner ear. The FTD was granted by the FTD’s Division of Neurology Products, which is for drugs that can […]

Continue reading …
Neoleukin completes merger with Aquinox Pharmaceuticals

US biopharma company Neoleukin Therapeutics has wrapped up a previously announced merger with Canadian pharma company Aquinox Pharmaceuticals. Headquartered in Vancouver, Aquinox Pharmaceuticals focused on discovering and developing novel therapeutics for conditions related to inflammation, inflammatory pain, and blood cancers. On the other hand, Neoleukin creates next-generation immunotherapies by using its de novo protein design […]

Continue reading …